Izotropic Corporation (CSE:IZO)

Market Cap	25.31M
Revenue (ttm)	n/a
Net Income (ttm)	-2.31M
Shares Out	66.61M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,675
Average Volume	51,227
Open	0.3850
Previous Close	0.3800
Day's Range	0.3600 - 0.3850
52-Week Range	0.0350 - 0.4550
Beta	1.22
RSI	53.26
Earnings Date	Sep 26, 2025

About Izotropic

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360‐degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2016
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: IZO